ABRAZO ARROWHEAD CAMPUS — History
CCN 030094 | 3-year financial timeline | COVID resilience: 65/100
🛡️ Public data only — no PHI permitted on this instance.
$406M
Latest Revenue (FY2022)
+7.3%
Revenue CAGR (3yr)
11.7%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $353M | $404M | $406M | +0.5% | +7.3% |
| Operating Expenses | $323M | $349M | $359M | +2.8% | +5.4% |
| Operating Margin | 8.4% | 13.7% | 11.7% | -14.3% | +17.8% |
| Net Income | $30M | $55M | $48M | -13.8% | +26.5% |
| Licensed Beds | 270 | 270 | 270 | +0.0% | +0.0% |
| Total Patient Days | 66,149 | 69,689 | 64,869 | -6.9% | -1.0% |
| Medicare Day % | 23% | 21% | 20% | -4.1% | -5.8% |
| Medicaid Day % | 5% | 3% | 3% | -5.2% | -31.7% |
COVID Impact & Recovery
Resilience Score: 65/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +15.1% ($353M → $406M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+7.3%
This Hospital
+7.6%
State Avg
Latest Margin
11.7%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $433M | 13.3% |
| FY2024 (proj) | $460M | 15.0% |
| FY2025 (proj) | $487M | 16.6% |